oxymetazoline hydrochloride 10 MG/ML Topical Cream [Rhofade]
- RxCUI
- 1869821
- RxNorm name
- oxymetazoline hydrochloride 10 MG/ML Topical Cream [Rhofade]
- Display name
- RHOFADE (Topical)
- Full name
- oxymetazoline hydrochloride 10 MG/ML Topical Cream [Rhofade]
- Term type
- SBD
- Status
- Active
- Strength
- 1%
- Dose form
- Cream
- Route
- Topical
- Updated
- 2026-10-27 19:27:59
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 032017
- Active start
- 032017
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| oxymetazoline hydrochloride | 10 MG / 1 ML | oxymetazoline | oxymetazoline hydrochloride |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Topical Cream | 316982 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| oxymetazoline | 7812 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Rhofade 1 % Topical Cream | 1 | NAMES |
| RxNorm Name | oxymetazoline hydrochloride 10 MG/ML Topical Cream [Rhofade] | 1 | NAMES |
| RxNorm Synonym | 2 linked values | 2 | NAMES |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | 3 | CODES | |
| RxCUI | 1869821 | 1 | CODES |
| MMSL_CODE | BD31741 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 51862-765-00 | 51862-765 | Rhofade oxymetazoline hydrochloride | Mayne Pharma | NDA208552 |
| 51862-765-30 | 51862-765 | Rhofade oxymetazoline hydrochloride | Mayne Pharma | NDA208552 |
| 71403-003-15 | 71403-003 | Rhofade OXYMETAZOLINE HYDROCHLORIDE | EPI Health, LLC | NDA208552 |
| 71403-003-30 | 71403-003 | Rhofade OXYMETAZOLINE HYDROCHLORIDE | EPI Health, LLC | NDA208552 |
Drugs@FDA Applications#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rhofade | OXYMETAZOLINE HYDROCHLORIDE | Mayne Pharma | 34298db6-647d-480d-88a8-dc53258a5164 | 2026-07-13 | Warnings, Adverse reactions | 68308076630 1869821 |
| Rhofade | OXYMETAZOLINE HYDROCHLORIDE | Mayne Pharma | f7dbf12e-a802-4261-bae2-c20977698933 | 2025-06-27 | Warnings, Adverse reactions | 51862-765-00 51862-765-30 51862-765 51862076500 51862076530 1869821 |
| Rhofade | OXYMETAZOLINE HYDROCHLORIDE | EPI Health, LLC | e82b5788-a855-4165-a81f-7f15cb874612 | 2023-05-09 | Warnings, Adverse reactions | 71403-003-15 71403-003-30 71403-003 71403000315 71403000330 1869821 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 8968299e-2a4f-41a8-9088-6343ea6c91f4 | Rhofade 1 % Topical Cream [PSN] · oxymetazoline hydrochloride 10 MG/ML Topical Cream [Rhofade] [SBD] · Rhofade 1 % Topical Cream [SY] · Rhofade 10 MG/ML Topical Cream [SY] | 4 | 3 | These highlights do not include all the information needed to use RHOFADE ® topical cream safely and effectively. See full prescribing information for RHOFADE ® topical cream. RHOFADE ® (oxymetazoline hydrochloride) cream, 1%, for topical use Initial U.S. Approval: 1964 | 20191031 |
| f7dbf12e-a802-4261-bae2-c20977698933 | Rhofade 1 % Topical Cream [PSN] · oxymetazoline hydrochloride 10 MG/ML Topical Cream [Rhofade] [SBD] · Rhofade 1 % Topical Cream [SY] · Rhofade 10 MG/ML Topical Cream [SY] | 4 | 2 | These highlights do not include all the information needed to use RHOFADE ® topical cream safely and effectively. See full prescribing information for RHOFADE ® topical cream. RHOFADE ® (oxymetazoline hydrochloride) cream, 1%, for topical use Initial U.S. Approval: 1964 | 20250627 |
| e82b5788-a855-4165-a81f-7f15cb874612 | Rhofade 1 % Topical Cream [PSN] · oxymetazoline hydrochloride 10 MG/ML Topical Cream [Rhofade] [SBD] · Rhofade 1 % Topical Cream [SY] · Rhofade 10 MG/ML Topical Cream [SY] | 4 | 2 | These highlights do not include all the information needed to use RHOFADE ® topical cream safely and effectively. See full prescribing information for RHOFADE ® topical cream. RHOFADE ® (oxymetazoline hydrochloride) cream, 1%, for topical use Initial U.S. Approval: 1964 | 20230509 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 34298db6-647d-480d-88a8-dc53258a5164 | These highlights do not include all the information needed to use Oxymetazoline Hydrochloride Cream safely and effectively. See full prescribing information for Oxymetazoline Hydrochloride Cream. Oxymetazoline Hydrochloride Cream, 1%, for topical use Initial U.S. Approval: 1964 | Mayne Pharma | DPT Laboratories, Ltd. | 20260713 |
| f7dbf12e-a802-4261-bae2-c20977698933 | These highlights do not include all the information needed to use RHOFADE ® topical cream safely and effectively. See full prescribing information for RHOFADE ® topical cream. RHOFADE ® (oxymetazoline hydrochloride) cream, 1%, for topical use Initial U.S. Approval: 1964 | Mayne Pharma | DPT Laboratories, Ltd. | 20250627 |
| e82b5788-a855-4165-a81f-7f15cb874612 | These highlights do not include all the information needed to use RHOFADE ® topical cream safely and effectively. See full prescribing information for RHOFADE ® topical cream. RHOFADE ® (oxymetazoline hydrochloride) cream, 1%, for topical use Initial U.S. Approval: 1964 | EPI Health, LLC | DPT Laboratories, Ltd. | 20230509 |
| 8968299e-2a4f-41a8-9088-6343ea6c91f4 | These highlights do not include all the information needed to use RHOFADE ® topical cream safely and effectively. See full prescribing information for RHOFADE ® topical cream. RHOFADE ® (oxymetazoline hydrochloride) cream, 1%, for topical use Initial U.S. Approval: 1964 | Aclaris Therapeutics, Inc. | DPT Laboratories, Ltd. | 20191031 |
| 1ba1cc5b-4f7f-491b-a5af-a6a14fb5affd | These highlights do not include all the information needed to use RHOFADE ™ topical c ream safely and effectively. See full prescribing information for RHOFADE ™ topical c ream . RHOFADE ™ ( oxymetazoline hydrochloride ) cream , for topical use Initial U.S. Approval: 1964 | Allergan, Inc. | DPT Laboratories, Ltd. | 20170101 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | D11AX | Other dermatologicals | ATC1-4 | oxymetazoline | |
| ATC | S01GA | Sympathomimetics used as decongestants | ATC1-4 | oxymetazoline | |
| ATC | R01AB | Sympathomimetics, combinations excl. corticosteroids | ATC1-4 | oxymetazoline | |
| ATC | R01AA | Sympathomimetics, plain | ATC1-4 | oxymetazoline | |
| FDASPL | D048288 | Imidazolines | CHEM | has_chemical_structure | oxymetazoline |
| FDASPL | N0000192562 | Vasoconstrictor | EPC | has_epc | oxymetazoline |
| FDASPL | N0000175651 | Increased Sympathetic Activity | PE | has_pe | oxymetazoline |
| FDASPL | N0000009908 | Vasoconstriction | PE | has_pe | oxymetazoline |
| MEDRT | D010109 | Oxymetazoline | CHEM | has_ingredient | oxymetazoline hydrochloride |
| MEDRT | D010109 | Oxymetazoline | CHEM | has_ingredient | oxymetazoline |
| MEDRT | D003139 | Common Cold | DISEASE | may_treat | oxymetazoline hydrochloride |
| MEDRT | D003139 | Common Cold | DISEASE | may_treat | oxymetazoline |
| MEDRT | D003231 | Conjunctivitis | DISEASE | may_treat | oxymetazoline hydrochloride |
| MEDRT | D003231 | Conjunctivitis | DISEASE | may_treat | oxymetazoline |
| MEDRT | D012220 | Rhinitis | DISEASE | may_treat | oxymetazoline |
| MEDRT | D012220 | Rhinitis | DISEASE | may_treat | oxymetazoline hydrochloride |
| MEDRT | D012852 | Sinusitis | DISEASE | may_treat | oxymetazoline |
| MEDRT | D012852 | Sinusitis | DISEASE | may_treat | oxymetazoline hydrochloride |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | oxymetazoline |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | oxymetazoline hydrochloride |
| MEDRT | N0000008371 | Conjunctival Arterial Vasoconstriction | PE | has_pe | oxymetazoline |
| MEDRT | N0000008371 | Conjunctival Arterial Vasoconstriction | PE | has_pe | oxymetazoline hydrochloride |
| MEDRT | N0000008896 | Decreased Nasal and Sinus Secretions | PE | has_pe | oxymetazoline |
| MEDRT | N0000008896 | Decreased Nasal and Sinus Secretions | PE | has_pe | oxymetazoline hydrochloride |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 10 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | NDA | NDA208552 |
| NAMES | Prescribable Synonym | Rhofade 1 % Topical Cream |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |